Top

Published in:

01-01-2015 | Original Contributions

Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up

Authors: Pilar Sanchis, Carla Frances, Joana Nicolau, Rosmeri Rivera, Regina Fortuny, Xavier Julian, Salvador Pascual, Luis A. Gomez, Irene Rodriguez, Josefina Olivares, Luisa Ayala, Luis Masmiquel

Published in: Obesity Surgery | Issue 1/2015

Abstract

Background

The aim was to compare obesity-related cardiovascular (CV) risk factors (classic and emerging) and the estimated CV risk at 10 years (calculated by REGICOR) in obese Mediterranean patients submitted to bariatric surgery and intensive lifestyle intervention at baseline and after 1 year of follow-up.

Methods

Patients submitted to bariatric surgery (n = 108) and standardized program of therapeutic changes in lifestyle (n = 90) were retrospectively included. Clinical history, physical examination, and laboratory analysis were routinely determined before weight loss intervention and at 1 year follow-up.

Results

Seventy-five percent of the surgery patients had a CV risk lower than 5 % and not one patient had a 10-year CV risk higher than 15 %. The percentage of patients with comorbidities (diabetes and sleep apnea syndrome) was higher in the surgery group. Seventeen of the surgery patients had no comorbidities. The improvement in CV risk profile was significant higher in the surgery group. CV risk benefit of both intervention groups was related to baseline higher CV risk, with type 2 diabetes with poor metabolic control and high cholesterol levels being the most important predictors for surgery patients. Neither body mass index nor excess of weight loss was related to CV risk improvement.

Conclusions

Mediterranean patients undergoing a weight loss intervention have a low CV risk. In comparison with lifestyle intervention, surgery induces a better improvement of CV risk. This benefit is related to estimated CV risk, presence of diabetes, and cholesterol levels at baseline. These observations should be taken into account in order to optimize health resources.

Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–78.PubMedCrossRef

Vest AR, Heneghan HM, Schauer PR, et al. Surgical management of obesity and the relationship to cardiovascular disease. Circulation. 2013;127(8):945–59. doi:10.1161/CIRCULATIONAHA.112.103275.PubMedCrossRef

Jiang J, Ahn J, Huang WY, et al. Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med. 2013;57(1):60–4. doi:10.1016/j.ypmed.2013.04.014.PubMedCentralPubMedCrossRef

The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2013. doi:10.1016/S0140-6736(13)61836-X.

Must A, Spadano Van Gaal LF, Maggioni AP. Overweight, obesity, and outcomes: fat mass and beyond. Lancet. 2013. doi:10.1016/S0140-6736(13)62076-0.

Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9. doi:10.1056/NEJMoa1000367.PubMedCrossRef

Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290(7):932–40.PubMedCrossRef

Tzotzas T, Evangelou P, Kiortsis DN. Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev. 2011;12(5):e282–9. doi:10.1111/j.1467-789X.2010.00807.x.PubMedCrossRef

Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93. doi:10.1056/NEJMoa035622.PubMedCrossRef

10.

Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61. doi:10.1056/NEJMoa066603.PubMedCrossRef

11.

Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. doi:10.1001/jama.2011.1914.PubMedCrossRef

12.

Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. doi:10.1001/jama.299.3.316.PubMedCrossRef

13.

Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735–45. doi:10.1530/EJE-10-0514.PubMedCentralPubMedCrossRef

14.

Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36. doi:10.1007/s11695-012-0864-0.PubMedCrossRef

15.

Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90(1):15–22. doi:10.3945/ajcn.2009.27583.PubMedCrossRef

16.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81–90. doi:10.2337/dc14-S081.CrossRef

17.

Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5. doi:10.2337/dc09-9036.PubMedCentralPubMedCrossRef

18.

Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.PubMedCrossRef

19.

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.

20.

Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999 22(5):667-89.

21.

Wood D, De Backer G, Faergeman O, et al. Task Force Report. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of the joint European Societies on coronary prevention. Eur Heart J. 1998;19(10):1434–503.CrossRef

22.

Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 16;285(19):2486-97.

23.

Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110(2):227–39.PubMedCrossRef

24.

Anderson KM, Wilson PWF, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83(1):356–62.PubMedCrossRef

25.

Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.PubMedCrossRef

26.

Menotti A, Lanti M, Puddu PE, et al. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 2000;84(3):238–44.PubMedCentralPubMedCrossRef

27.

Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000;21(5):365–70.PubMedCrossRef

28.

Marrugat J, Solanas P, D’Agostino R, et al. Coronary risk estimation in Spain using a calibrated Framingham function. Rev Esp Cardiol. 2003;56(3):253–61.PubMedCrossRef

29.

Marrugat J, D'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary risk function to southern Europe Mediterranean areas. J Epidemiol Community Health. 2003;57(8):634–8.PubMedCentralPubMedCrossRef

30.

Comín E, Solanas P, Cabezas C, et al. Estimating cardiovascular risk in Spain using different algorithms. Rev Esp Cardiol. 2007;60(7):693–702.PubMedCrossRef

31.

Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care. 1979;2(2):120–6.PubMedCrossRef

32.

Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.PubMedCrossRef

33.

Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011;108(10):1499–507. doi:10.1016/j.amjcard.2011.06.076.PubMedCrossRef

34.

Ortega E, Morínigo R, Flores L, et al. Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc. 2012;26(6):1744–50. doi:10.1007/s00464-011-2104-4.PubMedCrossRef

35.

Dixon JB, Dixon ME, O'Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg. 2001;11(2):200–7.PubMedCrossRef

36.

Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701. doi:10.1161/CIR.0b013e3182149099.PubMedCrossRef

37.

Martins C, Strømmen M, Stavne OA, et al. Bariatric surgery versus lifestyle interventions for morbid obesity–changes in body weight, risk factors and comorbidities at 1 year. Obes Surg. 2011;21(7):841–9. doi:10.1007/s11695-010-0131-1.PubMedCrossRef

38.

Jacobson TA. Lipoprotein (a), cardiovascular disease, and contemporary management. Mayo Clin Proc. 2013;88(11):1294–311. doi:10.1016/j.mayocp.2013.09.003.PubMedCrossRef

39.

Thompson GR, Seed M. Lipoprotein (a): the underestimated cardiovascular risk factor. Heart. 2013. doi:10.1136/heartjnl-2013-304902.PubMed

40.

Dixon JB, Dixon ME, O'Brien PE. Elevated homocysteine levels with weight loss after Lap-Band surgery: higher folate and vitamin B12 levels required to maintain homocysteine level. Int J Obes Relat Metab Disord. 2001;25(2):219–27.PubMedCrossRef

41.

Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237(6):751–6. discussion 757-8.PubMedCentralPubMed

42.

Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. doi:10.1056/NEJMoa1212914.PubMedCrossRef

43.

Gerstein HC. Do lifestyle changes reduce serious outcomes in diabetes? N Engl J Med. 2013;369(2):189–90. doi:10.1056/NEJMe1306987.PubMedCrossRef

44.

Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care. 2010;33(2):442–9. doi:10.2337/dc09-0749.PubMedCentralPubMedCrossRef

45.

Edward H, Livingston MD. Inadequacy of BMI as an indicator for bariatric surgery. JAMA. 2012;307(1):88–9. doi:10.1001/jama.2011.1950.CrossRef

46.

Livingston EH. Pitfalls in using BMI as a selection criterion for bariatric surgery. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):347–51. doi:10.1097/MED.0b013e328357f0b8.PubMedCrossRef

47.

Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One. 2012;7(4):e33308. doi:10.1371/journal.pone.0033308.PubMedCentralPubMedCrossRef

48.

Gómez-Ambrosi J, Silva C, Galofré JC, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36(2):286–94. doi:10.1038/ijo.2011.100.CrossRef

49.

Gómez-Ambrosi J, Silva C, Catalán V, et al. Clinical usefulness of a new equation for estimating body fat. Diabetes Care. 2012;35(2):383–8.PubMedCentralPubMedCrossRef

50.

Benaiges D, Goday A, Ramon JM, et al. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis. 2011;7(5):575–80. doi:10.1016/j.soard.2011.03.002.PubMedCrossRef

Title: Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up
Authors: Pilar Sanchis
Carla Frances
Joana Nicolau
Rosmeri Rivera
Regina Fortuny
Xavier Julian
Salvador Pascual
Luis A. Gomez
Irene Rodriguez
Josefina Olivares
Luisa Ayala
Luis Masmiquel
Publication date: 01-01-2015
Publisher: Springer US
Published in: Obesity Surgery / Issue 1/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-014-1321-z

ACC 2024 Congress

Springer Medicine

Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Second-Stage Robot-Assisted Biliopancreatic Diversion with Duodenal Switch After Sleeve Gastrectomy

Laparoscopic Roux-en-Y Gastric Bypass: Creation of the Neogastric Pouch

Duodeno-Jejunal Tube Placement in an Experimental Model of Obesity: Effects on Food Behaviour and Basal Energy Expenditure

Effect of a Post-operative Structured Exercise Programme on Short-Term Weight Loss After Obesity Surgery Using Adjustable Gastric Bands

Bariatric Surgery and Liver Transplantation: a Systematic Review a New Frontier for Bariatric Surgery

Laparoscopic Gastric Sleeve, Subtotal Antrectomy and Omentoplasty